ISRCTN31981313终止未知
Autologous Stem cell Transplantation In refractory Crohn’s disease – Low Intensity Therapy Evaluation (ASTIClite) – long-term follow up through the EBMT
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 入组人数
- 99
研究概览
简要总结
2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31151436/ (added 11/08/2022)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Participants must have consented to take part in the ASTIClite randomised controlled trial (see http://www.isrctn.com/ISRCTN17160440)
- •2. Participants must be willing and able to provide full informed consent, including sharing their data with the EBMT
排除标准
- •Significant language barriers, which are likely to affect the participant’s understanding of the study, or ability to complete outcome questionnaires
研究者
相似试验
已完成
3 期
A randomised controlled trial to assess the safety and effectiveness of stem cell transplantation using a reduced intensity regimen in patients with treatment resistant Crohn’s diseaseCrohn's diseaseISRCTN17160440Barts Health NHS Trust45
进行中（未招募）
1 期
Controlled trial to assess low intensity autologous stem cell transplant in refractory Crohn's DiseaseEUCTR2017-002545-30-GBBarts Health NHS Trust99
已完成
2 期
pfront autologous stem cell transplantation for primaly peripheral T cell lymphomaALK-ngative Anaplastic large cell lymphoma(ALCL), Angioimmunoblastic T-cell lymphoma(AITL), Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)JPRN-UMIN000028831Tosei General Hospital Department of Hematology and Oncology19
进行中（未招募）
不适用
A study of the benefit of fat transfer to the peri-oral area for scleroderma patientsPerioral fibrosis of systemic sclerosis (scleroderma)Musculoskeletal DiseasesISRCTN17793055C50
已完成
1 期
Allogeneic stem cell transplantation for relapsed/refractory aggressive lymphoma with conditioning regimen consisted of fludarabine, iv busulfan, and melphalan (single center prospective trial)JPRN-UMIN000013940Department of Hematology Toranomon Hospital12